{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:09Z","timestamp":1789913589531,"version":"4.0.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":2022,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,15]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Post-kala-azar dermal leishmaniasis (PKDL) is a chronic dermal complication that occurs usually after recovery from visceral leishmaniasis (VL). The disease manifests into macular, papular and\/or nodular clinical types with mono- or polymorphic presentations. Here, we investigated differences in immunological response between these two distinct clinical forms in Indian PKDL patients. Peripheral blood mononuclear cells of PKDL and naive individuals were exposed in vitro to total soluble Leishmania antigen (TSLA). The proliferation index was evaluated using an enzyme-linked immunosorbent assay (ELISA)-based lymphoproliferative assay. Cytokines and granzyme B levels were determined by cytometric bead array. Parasite load in tissue biopsy samples of PKDL was quantified by quantitative polymerase chain reaction (qPCR). The proportion of different lymphoid subsets in peripheral blood and the activated T cell population were estimated using flow cytometry. The study demonstrated heightened cellular immune responses in the polymorphic PKDL group compared to the naive group. The polymorphic group showed significantly higher lymphoproliferation, increased cytokines and granzyme B levels upon TSLA stimulation, and a raised proportion of circulating natural killer (NK) T cells against naive controls. Furthermore, the polymorphic group showed a significantly elevated proportion of activated CD4+ and CD8+ T cells upon in-vitro TSLA stimulation. Thus, the polymorphic variants showed pronounced cellular immunity while the monomorphic form demonstrated a comparatively lower cellular response. Additionally, the elevated level of both activated CD4+ and CD8+ T cells, coupled with high granzyme B secretion upon in-vitro TSLA stimulation, indicated the role of cytotoxic cells in resistance to L. donovani infection in polymorphic PKDL.<\/jats:p>","DOI":"10.1111\/cei.12787","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T09:56:52Z","timestamp":1457344612000},"page":"50-60","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India"],"prefix":"10.1093","volume":"185","author":[{"given":"H","family":"Kaushal","sequence":"first","affiliation":[{"name":"National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bras-Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Institut de Recherche pour le D\u00e9veloppement, Montpellier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Avishek","sequence":"additional","affiliation":[{"name":"National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kumar Deep","sequence":"additional","affiliation":[{"name":"National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Petitdidier","sequence":"additional","affiliation":[{"name":"Institut de Recherche pour le D\u00e9veloppement, Montpellier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L","family":"Lemesre","sequence":"additional","affiliation":[{"name":"Institut de Recherche pour le D\u00e9veloppement, Montpellier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Papierok","sequence":"additional","affiliation":[{"name":"Virbac, Carros, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, VMMC and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Salotra","sequence":"additional","affiliation":[{"name":"National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"key":"2021111804093475500_cei12787-bib-0001","first-page":"104","article-title":"Control of the leishmaniases","volume":"949","author":"World Health Organization (WHO).","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2021111804093475500_cei12787-bib-0002","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0020-7519(00)00136-3","article-title":"The leishmaniases as emerging and reemerging zoonoses","volume":"30","author":"Ashford","year":"2000","journal-title":"Int J Parasitol"},{"key":"2021111804093475500_cei12787-bib-0003","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLOS ONE"},{"key":"2021111804093475500_cei12787-bib-0004","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2133.2000.03603.x","article-title":"Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis","volume":"143","author":"Zijlstra","year":"2000","journal-title":"Br J Dermatol"},{"key":"2021111804093475500_cei12787-bib-0005","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2007.01854.x","article-title":"Short communication: post-kala-azar dermal leishmaniasis \u2013 an appraisal","volume":"12","author":"Ramesh","year":"2007","journal-title":"Trop Med Int Health"},{"key":"2021111804093475500_cei12787-bib-0006","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.1371\/journal.pntd.0000832","article-title":"Enhanced case detection and improved diagnosis of PKDL in a kala-azar-endemic area of Bangladesh","volume":"4","author":"Mondal","year":"2010","journal-title":"PLOS Negl Trop Dis"},{"key":"2021111804093475500_cei12787-bib-0007","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/648727","article-title":"Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh","volume":"50","author":"Rahman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2021111804093475500_cei12787-bib-0008","volume-title":"Post-kala-azar dermal leishmaniasis: a manual for case management and control","author":"World Health Organization (WHO)","year":"2012"},{"key":"2021111804093475500_cei12787-bib-0009","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-4632.2010.04558.x","article-title":"Post-kala-azar dermal leishmaniasis \u2013 an overview","volume":"49","author":"Ganguly","year":"2010","journal-title":"Int J Dermatol"},{"key":"2021111804093475500_cei12787-bib-0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0378-6323.148562","article-title":"Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients","volume":"81","author":"Singh","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2021111804093475500_cei12787-bib-0011","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<615::AID-PATH466>3.0.CO;2-Z","article-title":"Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile","volume":"189","author":"Ismail","year":"1999","journal-title":"J Pathol"},{"key":"2021111804093475500_cei12787-bib-0012","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/iai.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis","volume":"42","author":"Haldar","year":"1983","journal-title":"Infect Immun"},{"key":"2021111804093475500_cei12787-bib-0013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00034983.1988.11812205","article-title":"Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy","volume":"82","author":"Neogy","year":"1988","journal-title":"Ann Trop Med Parasitol"},{"key":"2021111804093475500_cei12787-bib-0014","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"key":"2021111804093475500_cei12787-bib-0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/JCM.39.3.849-854.2001","article-title":"Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis","volume":"39","author":"Salotra","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2021111804093475500_cei12787-bib-0016","doi-asserted-by":"crossref","first-page":"e10107","DOI":"10.1371\/journal.pone.0010107","article-title":"Quantification of parasite load in clinical samples of leishmaniasis patients: Il-10 level correlates with parasite load in visceral leishmaniasis","volume":"5","author":"Verma","year":"2010","journal-title":"PLOS ONE"},{"key":"2021111804093475500_cei12787-bib-0017","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1186\/s12889-015-2424-8","article-title":"Clinico-epidemiological analysis of post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study","volume":"15","author":"Ramesh","year":"2015","journal-title":"BMC Public Health"},{"key":"2021111804093475500_cei12787-bib-0018","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12879-014-0653-6","article-title":"Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals","volume":"14","author":"Kaushal","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2021111804093475500_cei12787-bib-0019","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2004-03-0859","article-title":"Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells","volume":"104","author":"Grossman","year":"2004","journal-title":"Blood"},{"key":"2021111804093475500_cei12787-bib-0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2021111804093475500_cei12787-bib-0021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-3083.1999.00470.x","article-title":"Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae","volume":"49","author":"Arv\u00e5","year":"1999","journal-title":"Scand J Immunol"},{"key":"2021111804093475500_cei12787-bib-0022","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/jid.2009.393","article-title":"Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis","volume":"130","author":"Ganguly","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2021111804093475500_cei12787-bib-0023","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.143.1.266","article-title":"Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H\/HeN mice to infection with Leishmania major","volume":"143","author":"Belosevic","year":"1989","journal-title":"J Immunol"},{"key":"2021111804093475500_cei12787-bib-0024","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cytogfr.2008.08.004","article-title":"IFNgamma signaling \u2013 does it mean JAK-STAT?","volume":"19","author":"Gough","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"2021111804093475500_cei12787-bib-0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2021111804093475500_cei12787-bib-0026","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2021111804093475500_cei12787-bib-0027","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","article-title":"Mixed inflammatory\/regulatory cytokine profile marked by simultaneous raise of interferon-\u03b3 and interleukin-10 and low frequency of tumour necrosis factor-\u03b1+ monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection","volume":"146","author":"Peruhype-Magalh\u00e3es","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2021111804093475500_cei12787-bib-0028","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/eji.1830270409","article-title":"Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation","volume":"27","author":"Vouldoukis","year":"1997","journal-title":"Eur J Immunol"},{"key":"2021111804093475500_cei12787-bib-0029","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/588387","article-title":"Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis","volume":"197","author":"Ganguly","year":"2008","journal-title":"J Infect Dis"},{"key":"2021111804093475500_cei12787-bib-0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.179.2.757","article-title":"Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3","volume":"179","author":"Bri\u00e8re","year":"1994","journal-title":"J Exp Med"},{"key":"2021111804093475500_cei12787-bib-0031","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0161-5890(96)00092-2","article-title":"Direct evidence that gamma 1 and gamma 3 switching in human B cells is interleukin-10 dependent","volume":"33","author":"Fujieda","year":"1996","journal-title":"Mol Immunol"},{"key":"2021111804093475500_cei12787-bib-0032","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity","volume":"265","author":"K\u00e4gi","year":"1994","journal-title":"Science"},{"key":"2021111804093475500_cei12787-bib-0033","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/382031","article-title":"Analysis of granzyme B activity as a surrogate marker of Leishmania specific cell mediated cytotoxicity in zoonotic cutaneous leishmaniasis","volume":"189","author":"Bousoffara","year":"2004","journal-title":"J Infect Dis"},{"key":"2021111804093475500_cei12787-bib-0034","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/370650a0","article-title":"Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways","volume":"370","author":"Lowin","year":"1994","journal-title":"Nature"},{"key":"2021111804093475500_cei12787-bib-0035","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1371\/journal.pntd.0000871","article-title":"CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists","volume":"4","author":"Hern\u00e1ndez-Ruiz","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2021111804093475500_cei12787-bib-0036","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/jid.2013.4","article-title":"CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFN\u03b3(+)-mediated parasite killing in human cutaneous leishmaniasis","volume":"133","author":"Santos","year":"2013","journal-title":"J Invest Dermatol"},{"key":"2021111804093475500_cei12787-bib-0037","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/IAI.02404-14","article-title":"Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection","volume":"83","author":"Cardoso","year":"2015","journal-title":"Infect Immun"},{"key":"2021111804093475500_cei12787-bib-0038","doi-asserted-by":"crossref","first-page":"e92708","DOI":"10.1371\/journal.pone.0092708","article-title":"In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis","volume":"9","author":"Chamakh-Ayari","year":"2014","journal-title":"PLOS ONE"},{"key":"2021111804093475500_cei12787-bib-0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-3083.1995.tb03527.x","article-title":"Subpopulations of T lymphocytes in the peripheral blood, dermal lesions and lymph nodes of post kala-azar dermal leishmaniasis patients","volume":"41","author":"Ghosh","year":"1995","journal-title":"Scand J Immunol"},{"key":"2021111804093475500_cei12787-bib-0040","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.181.5.3268","article-title":"Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors","volume":"181","author":"Patterson","year":"2008","journal-title":"J Immunol"},{"key":"2021111804093475500_cei12787-bib-0041","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.1841","article-title":"Raising the NKT cell family","volume":"11","author":"Godfrey","year":"2010","journal-title":"Nat Immunol"},{"key":"2021111804093475500_cei12787-bib-0042","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cyto.2015.01.011","article-title":"Leishmania donovani skews the CD56(+) natural killer T cell response during human visceral leishmaniasis","volume":"73","author":"Kumari","year":"2015","journal-title":"Cytokine"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12787","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/185\/1\/50\/41126930\/cei12787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/185\/1\/50\/41126930\/cei12787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:23:05Z","timestamp":1692246185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/185\/1\/50\/6412135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,4]]},"published-print":{"date-parts":[[2016,6,15]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12787","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,7]]},"published":{"date-parts":[[2016,5,4]]}}}